secwatch / observer
8-K filed February 22, 2023, 6:59 PM ET ticker TDOC CIK 0001477449
earnings confidence high sentiment negative materiality 0.85

Teladoc Health Q4 revenue up 15% to $637.7M; net loss of $3.81B on $3.77B goodwill impairment

Teladoc Health, Inc.

2022-FY EPS reported -$84.60 revenue$2,406,840,000

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Teladoc Health, Inc. reported Full Year 2022 results: revenue $2,406.8 million, net income ($13,659.5 million), EPS ($84.60) per share.

Period
Full Year 2022
Revenue
$2,406.8 million
Net income
($13,659.5 million)
EPS
($84.60) per share
Result
reported results
Exact text from the filing
Full Year Ended December 31, 2022 Revenue increased 18% to $2,406.8 million from $2,032.7 million for the year ended December 31, 2022 (“Full-Year 2022”). Access fees revenue grew 21% to $2,103.8 million, and other revenue grew 4% to $303.0 million. U.S. revenues and International revenues each grew 18% to $2,101.0 million and $305.8 million, respectively. Revenue increased 6% to $1,373.9 million for the Integrated Care segment and increased 41% to $1,019.6 million for the BetterHelp segment for Full-Year 2022. Non-cash goodwill impairment charges of $13.4 billion were recorded for Full-Year 2022. The non-cash charges had no impact on the provision for income taxes. Net loss totaled $13,659.5 million, or ($84.60) per share, for the year ended December 31,2022, compared to $428.8 million, or ($2.73) per share, for the year ended December 31, 2021.
View on SEC.gov
Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Teladoc Health, Inc. reported Fourth Quarter 2022 results: revenue $637.7 million, net income ($3,810.1 million), EPS ($23.49) per share.

Period
Fourth Quarter 2022
Revenue
$637.7 million
Net income
($3,810.1 million)
EPS
($23.49) per share
Result
reported results
Exact text from the filing
Fourth Quarter 2022 Revenue increased 15% to $637.7 million from $554.2 million in the fourth quarter of 2021. Access fees revenue grew 16% to $553.7 million and other revenue grew 10% to $84.0 million. U.S. Revenues grew 15% to $554.4 million and International revenues grew 17% to $83.3 million. Revenue increased 6% to $357.1 million for the Teladoc Health Integrated Care (“Integrated Care”) segment and increased 29% to $277.0 million for the BetterHelp segment in the fourth quarter of 2022. See note (9) in the Notes section that follows for further information regarding segment reporting. Non-cash goodwill impairment charges of $3.8 billion were recorded in the fourth quarter of 2022. The non-cash charges had no impact on the provision for income taxes. Net loss totaled $3,810.1 million, or ($23.49) per share, for the fourth quarter of 2022, compared to $11.0 million, or ($0.07) per share, for the fourth quarter of 2021.
View on SEC.gov

Browse all earnings releases →

Teladoc Health, Inc. filing history →

Source: SEC EDGAR
accession 0001558370-23-001751
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.